Bortezomib, free base, 100mg
To Order Contact us: lieven@wlsolutions.be
Rapamycin, 100mg |
||
| R5312-100mg | EUR 752 | |
YM158 (free base) |
||
| HY-U00355 | 1mg | EUR 2309 |
RPR107393 free base |
||
| HY-100299 | 1mg | EUR 481 |
FR167344 free base |
||
| HY-100301 | 1mg | EUR 2637 |
FR183998 free base |
||
| HY-100302 | 1mg | EUR 1127 |
FR194738 free base |
||
| HY-100303 | 1mg | EUR 1990 |
Vatalanib (free base) |
||
| HY-10203 | 5mg | EUR 119 |
Masupirdine (free base) |
||
| HY-109118 | 1mg | EUR 223 |
R406 (free base) |
||
| HY-11108 | 10mM/1mL | EUR 231 |
ITI214 (free base) |
||
| HY-12501 | 100mg | EUR 2943 |
AS2863619 (free base) |
||
| HY-126675 | 5mg | EUR 1175 |
AZD3839 (free base) |
||
| HY-13438 | 50mg | EUR 1014 |
Ripasudil free base |
||
| HY-15685A | 10mg | EUR 408 |
AZD4547, Free Base |
||
| ADC-P-063 | unit | Ask for price |
AZD8055, Free Base |
||
| ADC-P-064 | unit | Ask for price |
Cyclopamine, Free Base |
||
| ADC-P-079 | unit | Ask for price |
Ixabepilone, Free Base |
||
| ADC-P-104 | unit | Ask for price |
R406(free base) |
||
| E1KS1533 | 2mg | EUR 521 |
TMB free base |
||
| TB0954 | 1g | EUR 70.88 |
LY2835219 free base |
||
| A3575-100 | 100 mg | EUR 572 |
|
Description: LY2835219 is an orally available cyclin-dependent kinase (CDK) inhibitor that targets the CDK4 (cyclin D1) and CDK6 (cyclin D3) cell cycle pathway, with potential antineoplastic activity. |
||
LY2835219 free base |
||
| A3575-25 | 25 mg | EUR 258 |
|
Description: LY2835219 is an orally available cyclin-dependent kinase (CDK) inhibitor that targets the CDK4 (cyclin D1) and CDK6 (cyclin D3) cell cycle pathway, with potential antineoplastic activity. |
||
LY2835219 free base |
||
| A3575-5 | 5 mg | EUR 142 |
|
Description: LY2835219 is an orally available cyclin-dependent kinase (CDK) inhibitor that targets the CDK4 (cyclin D1) and CDK6 (cyclin D3) cell cycle pathway, with potential antineoplastic activity. |
||
R406 (free base) |
||
| A5880-100 | 100 mg | EUR 1210 |
|
Description: R406 is a potent SYK inhibitorSpleen tyrosine kinase (SYK) is a non-receptor tyrosine kinase mainly expressed in hematopoietic cells. It transmits signals from a variety of cell surface receptors including CD74, Fc receptor and integrins. |
||
R406 (free base) |
||
| A5880-25 | 25 mg | EUR 514 |
|
Description: R406 is a potent SYK inhibitorSpleen tyrosine kinase (SYK) is a non-receptor tyrosine kinase mainly expressed in hematopoietic cells. It transmits signals from a variety of cell surface receptors including CD74, Fc receptor and integrins. |
||
R406 (free base) |
||
| A5880-5 | 5 mg | EUR 166 |
|
Description: R406 is a potent SYK inhibitorSpleen tyrosine kinase (SYK) is a non-receptor tyrosine kinase mainly expressed in hematopoietic cells. It transmits signals from a variety of cell surface receptors including CD74, Fc receptor and integrins. |
||
R406 (free base) |
||
| A5880-5.1 | 10 mM (in 1mL DMSO) | EUR 264 |
|
Description: R406 is a potent SYK inhibitorSpleen tyrosine kinase (SYK) is a non-receptor tyrosine kinase mainly expressed in hematopoietic cells. It transmits signals from a variety of cell surface receptors including CD74, Fc receptor and integrins. |
||
R406 (free base) |
||
| A5880-S | Evaluation Sample | EUR 81 |
|
Description: R406 is a potent SYK inhibitorSpleen tyrosine kinase (SYK) is a non-receptor tyrosine kinase mainly expressed in hematopoietic cells. It transmits signals from a variety of cell surface receptors including CD74, Fc receptor and integrins. |
||
Xylazine (free base) |
||
| Q-1445.0025 | 25.0g | EUR 321 |
|
Description: Sum Formula: C12H16N2S; CAS# [7361-61-7] |
||
Rucaparib (free base) |
||
| A8893-10 | 10 mg | EUR 200 |
|
Description: Rucaparib, also named as AG-014699 or PF-01367338, is a poly (ADP ribose) polymerase (PARP) inhibitor. PARP is a DNA damage-activated nuclear enzyme that has a key signaling role in the base excision repair pathway. |
||
Rucaparib (free base) |
||
| A8893-200 | 200 mg | EUR 1036 |
|
Description: Rucaparib, also named as AG-014699 or PF-01367338, is a poly (ADP ribose) polymerase (PARP) inhibitor. PARP is a DNA damage-activated nuclear enzyme that has a key signaling role in the base excision repair pathway. |
||
Rucaparib (free base) |
||
| A8893-5 | 5 mg | EUR 137 |
|
Description: Rucaparib, also named as AG-014699 or PF-01367338, is a poly (ADP ribose) polymerase (PARP) inhibitor. PARP is a DNA damage-activated nuclear enzyme that has a key signaling role in the base excision repair pathway. |
||
Rucaparib (free base) |
||
| A8893-5.1 | 10 mM (in 1mL DMSO) | EUR 142 |
|
Description: Rucaparib, also named as AG-014699 or PF-01367338, is a poly (ADP ribose) polymerase (PARP) inhibitor. PARP is a DNA damage-activated nuclear enzyme that has a key signaling role in the base excision repair pathway. |
||
Rucaparib (free base) |
||
| A8893-50 | 50 mg | EUR 456 |
|
Description: Rucaparib, also named as AG-014699 or PF-01367338, is a poly (ADP ribose) polymerase (PARP) inhibitor. PARP is a DNA damage-activated nuclear enzyme that has a key signaling role in the base excision repair pathway. |
||
MCC950 (Free base) |
||
| B1031-1 | EUR 153 | |
MCC950 (Free base) |
||
| B1031-5 | EUR 457 | |
Apatinib (Free base) |
||
| B1613-25 | EUR 414 | |
Apatinib (Free base) |
||
| B1613-5 | EUR 142 | |
Carubicin (Free base) |
||
| B1853-1 | EUR 153 | |
Carubicin (Free base) |
||
| B1853-5 | EUR 457 | |
Anlotinib, free base |
||
| B2156-25 | EUR 588 | |
Anlotinib, free base |
||
| B2156-5 | EUR 185 | |
FIPI (free base) |
||
| B2372-25 | EUR 631 | |
FIPI (free base) |
||
| B2372-5 | EUR 196 | |
Terbinafine (Free base) |
||
| B2423-250 | EUR 207 | |
Terbinafine (Free base) |
||
| B2423-50 | EUR 120 | |
PLX5622 (free base) |
||
| B2965-25 | 25 mg | EUR 753 |
PLX5622 (free base) |
||
| B2965-5 | 5 mg | EUR 227 |
THZ1 (Free base) |
||
| 9664-25 | EUR 1023 | |
THZ1 (Free base) |
||
| 9664-5 | EUR 294 | |
Vatalanib, Free Base |
||
| 2026-25 | EUR 305 | |
Vatalanib, Free Base |
||
| 2026-5 | EUR 126 | |
Erlotinib, Free Base |
||
| 2048-100 | EUR 158 | |
Erlotinib, Free Base |
||
| 2048-1000 | EUR 387 | |
Sunitinib, Free base |
||
| 2097-100 | EUR 191 | |
Sunitinib, Free base |
||
| 2097-1000 | EUR 501 | |
Sunitinib, Free base |
||
| 2097-25 | EUR 115 | |
Lapatinib, Free base |
||
| 2138-100 | EUR 387 | |
Lapatinib, Free base |
||
| 2138-25 | EUR 191 | |
Ruxolitinib, Free base |
||
| 2139-100 | Ask for price | |
Ruxolitinib, Free base |
||
| 2139-25 | EUR 533 | |
Ruxolitinib, Free base |
||
| 2139-5 | EUR 207 | |
Imatinib, Free base |
||
| 2141-100 | EUR 147 | |
Imatinib, Free base |
||
| 2141-1000 | EUR 419 | |
Linsitinib, Free base |
||
| 2294-25 | EUR 566 | |
Linsitinib, Free base |
||
| 2294-5 | EUR 185 | |
Tipifarnib, Free base |
||
| 2296-1 | EUR 142 | |
Tipifarnib, Free base |
||
| 2296-5 | EUR 414 | |
Ruxolitinib (free base) |
||
| 10-042 | 25 mg | EUR 348.5 |
|
Description: Antineoplastic, anti-inflammatory and immunomodulating agent. Orally bioavailable potent ATP mimetic that inhibits both JAK1 and JAK2 with IC50 values of 2.7 and 4.5nM, respectively and is less selective for JAK3 (IC50=322nM). Affects DC differentiation and function, leading to impaired T cell activation. Used in the treatment of myeloproliferative neoplasms and psoriasis. Anticancer agent. Shown to induce apoptosis and autophagy. Potent and selective inhibitor of HIV-1 replication and virus reactivation in vitro. It is investigated against the spread of the SARS-CoV-2 (COVID-19). |
||
Doxorubicin HCl, 100mg |
||
| R2531-100mg | EUR 1300 | |
Cyclosporin A, 100mg |
||
| R5986-100mg | EUR 190 | |
Biotin-X, free acid:100mg |
||
| 90053 | 100MG | EUR 132 |
|
Description: Minimum order quantity: 1 unit of 100MG |
||
Bioin-XX, free acid: (100mg) |
||
| 90054 | 100MG | EUR 215 |
|
Description: Minimum order quantity: 1 unit of 100MG |
||
FK-448 Free base |
||
| HY-100193 | 10mg | EUR 1887 |
KW-8232 free base |
||
| HY-100304 | 10mg | EUR 5018 |
YM-53601 free base |
||
| HY-100313 | 1mg | EUR 1559 |
AV-412 (free base) |
||
| HY-10346A | 5mg | EUR 173 |
SB-334867 (free base) |
||
| HY-10895A | 10mg | EUR 215 |
SNT-207858 (free base) |
||
| HY-11030A | 10mg | EUR 911 |
APX-115 (free base) |
||
| HY-120801A | 5mg | EUR 223 |
LY-2584702 (free base) |
||
| HY-12493 | 5mg | EUR 165 |
Genz-123346 (free base) |
||
| HY-12744 | 10mM/1mL | EUR 189 |
YHO-13351 (free base) |
||
| HY-12758A | 10mM/1mL | EUR 176 |